| Catalog No | Package | Original Price | Price | Inventory | Quantity | Operating |
|---|---|---|---|---|---|---|
| SBP01676-5mg | 5mg | $490.00 | Sign in |
|
Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
β-Amyrone (β-Amyrone, CAS No.: 638-97-1) is a natural compound belonging to the sesquiterpene class and is widely found in resins and essential oils of various plants. As a natural compound with significant biological activity, β-aroma resin ketone has attracted widespread attention in the field of natural product pharmacology in recent years due to its unique chemical structure and multi-target pharmacological effects. Especially in terms of anti-inflammatory effects, β-aroma ketone demonstrates good activity, involving multiple inflammation-related signaling pathways and key molecular targets such as IL-6, STAT3, TNF, NFKB1, etc., demonstrating its potential value in the treatment of inflammatory diseases.
This paper aims to systematically review the chemical structure and physicochemical properties, plant origin and extraction methods, pharmacological activity studies, mechanisms of action and molecular targets, druggability evaluation, and pharmacokinetic characteristics of β-aroma ketone, as well as explore its clinical application prospects and future research directions, providing scientific basis and theoretical support for the development and utilization of this natural product.
β-aroma resin ketone has the molecular formula C30H48O and a molecular weight of 424.7130, belonging to the sesquiterpene ketone compound. Its structural features include a typical tricyclic terpene backbone containing ketone functional groups, which impart specific chemical reactivity to it. β-aroma resin ketone has a LogP value as high as 8.4091, showing extremely strong hydrophobicity, indicating good affinity in lipid environments, but very low water solubility (0.0001), which limits its direct application in aqueous solutions. Its topological pole surface area (TPSA) is 17.07 Ų, and its lower polarity facilitates penetration of cell membranes and the blood-brain barrier (BBB). Experimental data also confirm its high BBB penetration capability.
From a safety perspective, β-aroma resin ketone did not show hERG channel inhibition, suggesting a low risk of cardiotoxicity; The Ames test result was 0.0, indicating no significant genotoxicity. These physicochemical and safety parameters provide a solid foundation for the drug development of β-aroma ketone.
β-aroma ketone is mainly found in the resins and essential oils of various aromatic plants, especially in high levels in plants of the Aromaceae family (such as the genus Aromaticaceae) and certain Pinaceae species. Its natural sources are abundant, and plant extracts often contain other sesquiterpenes and terpene compounds, giving them complex pharmacological activity.
Traditional extraction methods mostly use solvent extraction combined with chromatography separation technology. Common solvents include ethanol, methanol, ethyl acetate, etc., which are purified by column chromatography after extraction (silica gel column, reversed-phase C18 column). In recent years, supercritical CO2 extraction technology, due to its high efficiency and environmental friendliness, has also been used for the extraction of β-aroma resin ketone, significantly improving extraction purity and yield. In addition, the application of modern technologies such as microwave-assisted extraction and ultrasonic-assisted extraction further optimizes the extraction process, reducing energy consumption and time costs.
Pharmacological studies on β-aroma ketone mainly focus on their anti-inflammatory effects. Both in vitro cell models and in vivo animal experiments have shown that β-aromatin ketone can significantly inhibit the release of inflammatory mediators and activation of inflammatory signaling pathways. Specifically, it inhibits the expression of pro-inflammatory cytokines such as tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6), reducing cyclooxygenase (PTGS1 and PTGS2) activity, thereby alleviating inflammatory responses.
Additionally, β-aroma ketone regulates inflammation-related ion channels such as TRPV1 and TRPA1, both of which play key roles in pain and inflammation signaling. By regulating these targets, β-vaneresin ketone not only reduces inflammation but also alleviates inflammation-related pain symptoms.
Recent studies have also found that β-aromatin ketone plays a role in regulating the expression of apoptosis-related enzymes CASP1 (caspase-1) and nitric oxide synthase 2 (NOS2), further revealing its multi-regulatory mechanisms in the inflammatory microenvironment.
The anti-inflammatory mechanism of β-aroma ketone involves multiple signaling pathways and key molecular targets. First, by inhibiting the nuclear factor κB (NFKB1) signaling pathway, it blocks the transcription expression of pro-inflammatory genes, reduces the production of cytokines such as TNF-α and IL-6, and alleviates inflammatory responses. The NFKB signaling pathway is the core regulatory pathway for inflammatory responses, and the effective inhibition of β-aroma ketone is the foundation of its anti-inflammatory activity.
Second, β-aromacerone affects signal transduction and the activity of transcription activator factor 3 (STAT3), which plays a key role in various inflammatory and immune responses. By modulating STAT3, β-aromacerone can inhibit the activation of inflammatory cells and the release of inflammatory mediators.
Additionally, β-aroma resin ketone modulates TRPV1 and TRPA1 ion channels, weakening neural excitability and pain transmission caused by inflammatory stimulation, thus possessing potential analgesic effects. CASP1, as the core enzyme of the inflammasome, participates in the maturation and release of the pro-inflammatory cytokine IL-1β. β-aromatone ketone inhibits CASP1 activity, blocks the activation of inflammasomes, and further suppresses the inflammatory cascade.
Finally, β-aromatic ketone inhibits PTGS1 (COX-1) and PTGS2 (COX-2), reduces prostaglandin synthesis, and alleviates inflammation and pain. Inhibition of NOS2 reduces excessive nitric oxide production at the inflamed site, alleviating oxidative stress and tissue damage.
In summary, β-aromatic ketone achieves comprehensive regulation of inflammatory responses through multi-target and multi-pathway synergistic effects, demonstrating promising anti-inflammatory potential.
The druggability evaluation of β-aroma ketone shows certain advantages and challenges. Its high lipid solubility (LogP=8.4091) and low polarity (TPSA=17.07) give it excellent cell membrane permeability and blood-brain barrier penetration, making it suitable for drug development for central nervous system-related diseases. However, its extremely low water solubility (0.0001) limits its bioavailability, requiring improved solubility and in vivo distribution through pharmaceutical formulation techniques (such as nanocarriers, liposomes, micelles, etc.).
In terms of safety, β-aroma resin ketone did not show hERG channel inhibition, reducing the risk of cardiotoxicity; A negative Ames test indicates no obvious genotoxicity and meets drug safety requirements.
Pharmacokinetic studies have shown that β-aromatin ketone has good distribution characteristics in the body, especially its ability to cross the blood-brain barrier, making it suitable for treating central nervous system inflammation and related diseases. Its metabolic pathway is not yet fully understood, but it is presumed to be mainly metabolized through oxidation and reduction reactions in the liver. The activity and safety of these metabolites require further research.
Based on the multi-target mechanism of β-aroma ketone in the anti-inflammatory field and its good safety profile, its clinical application prospects are broad. First, β-aromaceretone is expected to become a new natural medicine or adjunctive therapy for treating chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and neuroinflammation. Second, its regulatory effects on TRPV1 and TRPA1 give it potential advantages in managing inflammatory pain.
Additionally, the high blood-brain barrier permeability of β-aromaresin ketone offers potential applications in inflammatory diseases of the central nervous system, such as multiple sclerosis and Alzheimer's disease. In the future, improving its water solubility and bioavailability through structural modification and drug carrier technology will further enhance its clinical translation potential.
However, current clinical research on β-aroma ketone is relatively limited, urgently requiring systematic pharmacodynamics, toxicology, and preclinical research support to clarify its pharmacokinetic characteristics, dosage range, and safety evaluation, laying the foundation for clinical trials.
β-aroma resin ketone, as a natural sesquiterpene ketone compound with significant anti-inflammatory activity, demonstrates promising drug development potential due to its multi-target and multi-mechanism pharmacological effects. Its unique chemical structure endows it with excellent blood-brain barrier penetration and a lower risk of toxicity, providing a theoretical basis for its application in the treatment of inflammatory diseases, especially central nervous system inflammation.
Future research should focus on optimizing its formulations, improving water solubility and bioavailability, deeply elucidating its metabolic pathways and long-term safety, conducting systematic preclinical and clinical trials, and promoting β-aroma ketone from the laboratory to clinical applications, benefiting a wide range of patients. The continued development of natural product pharmacology will provide solid support for the innovative drug development of β-aroma ketone and similar compounds.
